COPY OF Sustained Strengthening of Public Health Laboratory, Transfusion Services, and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia
The summary for the COPY OF Sustained Strengthening of Public Health Laboratory, Transfusion Services, and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Centers for Disease Control CGH, which is the U.S. government agency offering this grant.
COPY OF Sustained Strengthening of Public Health Laboratory, Transfusion Services, and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia: Liberia is one of three West African nations most heavily affected by the Ebola virus disease (EVD). During the onset of EVD outbreak in Liberia, many hospitals and clinics were closed. As these facilities reopen it is imperative that Health Care Workers (HCW) remain vigilant to ensure that they are able to appropriately triage suspected EVD patients while protecting themselves from possible exposure. One of the highest risk groups for contracting EVD has been healthcare workers (HCW), with over 360 cases and 170 fatalities reported in this high-risk group in Liberia alone. This award will implement comprehensive Infection Prevention Control (IPC) training, as well as support and monitoring for Health Care Workers in Eastern Liberia. A second component of the award is to prioritize and strengthen clinical laboratory support that will provide more rapid diagnosis for EVD and other common illnesses in hospital laboratories and to support laboratory transport processes to reference laboratories. A major challenge is differentiating the diagnosis of Ebola which has non-specific initial symptoms such fever, vomiting, diarrhea from more common everyday diseases such as malaria, viral illnesses, or complicated pregnancy. Direct PCR testing or a rapid diagnostic within the hospital laboratory setting could play a crucial role in allowing patients with Ebola to be addressed appropriately. Another key component is to geographically align laboratories to maximize testing coverage, enhance transportation of specimens, and facilitate the development of more comprehensive testing, education, and training opportunities for Liberian laboratory technicians. In addition, this is an unparalleled opportunity to strengthen blood transfusion services for the country of Liberia. Convalescent plasma and whole blood have been used extensively for the treatment of Ebola on the basis that antibodies to Ebola virus within the plasma of survivors could confer immunity or partial immunity for the acutely ill EVD patient. While definitive studies have yet to prove the efficacy of convalescent plasma in controlled trials, for patients in the US during this epidemic, convalescent plasma has become an unofficial standard of treatment. Within Liberia, the Bill and Melinda Gates Foundation is currently funding an ongoing clinical trial at ELWA to test the efficacy of convalescent plasma. Improving donor collection and implementing component therapy allowing for the collection and storage of convalescent plasma could provide larger-scale life-saving therapy and potentially prophylaxis during this current outbreak in Liberia, as well as other affect West African nations, and if stored could help in the treatment of future outbreaks in the near-term or long-term.
Federal Grant Title: | COPY OF Sustained Strengthening of Public Health Laboratory, Transfusion Services, and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia |
Federal Agency Name: | Centers for Disease Control CGH (HHS-CDC-CGH) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | CDC-RFA-GH15-16300301SUPP17 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.318 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | April 27th, 2017 |
Original Application Deadline: | April 27th, 2017 |
Posted Date: | March 31st, 2017 |
Creation Date: | March 31st, 2017 |
Archive Date: | May 27th, 2017 |
Total Program Funding: | $20,000,000 |
Maximum Federal Grant Award: | $10,000,000 |
Minimum Federal Grant Award: | $0 |
Expected Number of Awards: | 1 |
Cost Sharing or Matching: | No |
Last Updated: | March 31st, 2017 |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- University of Massachusetts Medical School (UMASS), Academic Consortium Combating Ebola in Liberia (ACCEL)
- Grant Announcement Contact
- Locola Hayes
[email protected]
Grants Policy - Similar Government Grants
- • Public Health Partnerships to Accelerate Prevention and Control of Infectious Diseases and...
- • Achieving Global Health Security Through Strengthening Public Health Emergency Preparednes...
- • Advancing Diagnostic Network Optimization, Stepwise Laboratory Accreditation, and Integrat...
- • Strengthening immunization program implementation in sub-national consequential geographie...
- • Public Health Systems Capacity Building in Central Asia
- • Improving the Capacity of Panel Physicians Performing Overseas Medical Examinations of U.S...
- • Protecting and Improving Public Health Globally: Building and Strengthening Public Health ...
- More Grants from the Centers for Disease Control CGH
- • Technical Assistance to Deliver Comprehensive HIV/AIDS Prevention, Care and Treatment Acti...
- • Building an Effective, Robust and Sustainable Integrated Sample Transportation System in C...
- • Strengthening Mozambique's Capacity to Integrate and Sustain High-Quality Laboratory Servi...
- • Enhancing HIV Prevention, Care and Treatment Services through Patient Empowerment, Communi...
- • Implementing Evidence-Based Prevention Interventions for Key and Priority Populations in t...